Genocea Biosciences Inc (GNCA) Insider Trading
- $35,265,374.03
- $3,600,085.53
- June 1, 2022
- Jessica Baker Flechtner
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| June 1, 2022 | Insider | 2,500 | $0.06 | Sell | $150.00 | |
| May 31, 2022 | CEO | 117,244 | $0.06 | Sell | $7,034.64 | |
| May 26, 2022 | CFO | 24,407 | $0.08 | Sell | $1,952.56 | |
| May 25, 2022 | Director | 4,445,093 | $0.08 | Sell | $355,607.44 | |
| May 25, 2022 | Insider | 16,525 | $0.09 | Sell | $1,487.25 | |
| May 24, 2022 | Major Shareholder | 5,931,843 | $0.07 | Sell | $415,229.01 | |
| April 4, 2022 | CFO | 963 | $1.25 | Sell | $1,203.75 | |
| April 4, 2022 | Insider | 1,212 | $1.25 | Sell | $1,515.00 | |
| April 4, 2022 | CEO | 3,924 | $1.25 | Sell | $4,905.00 | |
| March 16, 2022 | Insider | 2,397 | $1.10 | Sell | $2,636.70 | |
| Nov. 10, 2020 | CEO | 4,760 | $2.06 | Buy | $9,805.60 | |
| July 24, 2020 | Major Shareholder | 3,151,260 | $2.25 | Buy | $7,090,335.00 | |
| June 24, 2019 | Major Shareholder | 2,857,142 | $3.50 | Buy | $9,999,997.00 | |
| Feb. 14, 2019 | Major Shareholder | 9,948,269 | $0.47 | Buy | $4,675,686.43 | |
| Sept. 13, 2018 | Insider | 10,000 | $0.54 | Buy | $5,400.00 | |
| Sept. 6, 2018 | Director | 25,000 | $0.61 | Buy | $15,250.00 | |
| Sept. 4, 2018 | Director | 25,000 | $0.62 | Buy | $15,500.00 | |
| Aug. 31, 2018 | Director | 25,000 | $0.61 | Buy | $15,250.00 | |
| Aug. 29, 2018 | Director | 25,000 | $0.61 | Buy | $15,250.00 | |
| Jan. 17, 2018 | CEO | 25,000 | $0.80 | Buy | $20,000.00 | |
| July 24, 2017 | CFO | 45,000 | $6.00 | Sell | $270,000.00 | |
| Nov. 8, 2016 | Insider | 7,000 | $3.49 | Buy | $24,430.00 | |
| Nov. 7, 2016 | CFO | 7,000 | $3.34 | Buy | $23,380.00 | |
| Nov. 7, 2016 | Insider | 2,800 | $3.49 | Buy | $9,772.00 | |
| May 9, 2016 | CFO | 4,000 | $3.88 | Buy | $15,520.00 | |
| Dec. 16, 2015 | CEO | 3,800 | $6.45 | Buy | $24,510.00 | |
| Sept. 1, 2015 | VP | 2,229 | $11.35 | Sell | $25,299.15 | |
| June 19, 2015 | Major Shareholder | 30,004 | $13.04 | Sell | $391,252.16 | |
| June 17, 2015 | Major Shareholder | 10,618 | $13.01 | Sell | $138,140.18 | |
| June 16, 2015 | Major Shareholder | 46,000 | $13.24 | Sell | $609,040.00 | |
| June 1, 2015 | VP | 2,229 | $10.52 | Sell | $23,449.08 | |
| May 1, 2015 | VP | 2,229 | $10.21 | Sell | $22,758.09 | |
| April 1, 2015 | VP | 2,283 | $11.77 | Sell | $26,870.91 | |
| March 17, 2015 | Director | 700,000 | $8.25 | Buy | $5,775,000.00 | |
| Feb. 2, 2015 | VP | 4,699 | $8.50 | Sell | $39,941.50 | |
| Sept. 12, 2014 | VP | 6,435 | $12.00 | Sell | $77,220.00 | |
| Sept. 11, 2014 | VP | 4,071 | $11.84 | Sell | $48,200.64 | |
| Sept. 10, 2014 | VP | 834 | $12.35 | Sell | $10,299.90 | |
| Sept. 9, 2014 | VP | 2,455 | $12.43 | Sell | $30,515.65 | |
| Sept. 8, 2014 | VP | 2,970 | $12.80 | Sell | $38,016.00 | |
| Aug. 29, 2014 | VP | 6,760 | $12.50 | Sell | $84,500.00 | |
| Aug. 14, 2014 | Major Shareholder | 9,660 | $13.01 | Sell | $125,676.60 | |
| Aug. 12, 2014 | Major Shareholder | 63,794 | $13.28 | Sell | $847,184.32 | |
| Feb. 10, 2014 | Insider | 143,773 | $12.00 | Buy | $1,725,276.00 | |
| Feb. 10, 2014 | Major Shareholder | 232,820 | $12.00 | Buy | $2,793,840.00 | |
| Feb. 10, 2014 | Director | 250,931 | $12.00 | Buy | $3,011,172.00 |
Insiders are both buying and selling Genocea Biosciences Inc stock.
The insider traders at Genocea Biosciences Inc are: Jessica Baker Flechtner, Polaris Venture Management Co., Paul Giannasca, William D Clark, George Siber, Jonathan Poole, Stephen J Hoffman, Paul Edward Walker, Peter W Sonsini, Diantha Duvall, William D. Clark, Eric S. Hoffman, Girish N Aakalu, Jacquelyn L Sumer, Michael Alfieri, Plc Glaxosmithkline, and Ali Behbahani
The most active insider trader at Genocea Biosciences Inc is Jessica Baker Flechtner with 8 trades.
Polaris Venture Management Co. has sold the most Genocea Biosciences Inc stock with a total value of $2,502,545.42.
Peter W Sonsini has bought the most Genocea Biosciences Inc stock with a total value of $24,675,680.43.
The most recent insider trade for Genocea Biosciences Inc was on June 1, 2022.
The single biggest insider buy for Genocea Biosciences Inc was from Peter W Sonsini with a total value of $9,999,997.00 on June 24, 2019.
The single biggest insider sell for Genocea Biosciences Inc was from Polaris Venture Management Co. with a total value of $847,184.32 on Aug. 12, 2014.